Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LANADELUMAB-FLYO: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

77.3%
Female
22.7%
Male

Age Information

The average age of patients reporting adverse events with LANADELUMAB-FLYO is 45.0 years.

Geographic Distribution

The majority of adverse event reports for LANADELUMAB-FLYO originate from US.

Report Summary & Outcomes

1,493
Total Reports
1,493
As Primary/Secondary Suspect
35
Deaths Reported
427
Hospitalizations
51
Life-Threatening
7
Disabilities

Reporting Timeline

First adverse event report: 20110101. Most recent report: 20250918. View full timeline →

More About LANADELUMAB-FLYO

LANADELUMAB-FLYO Full Profile Reports by Year Drug Interactions